Introducing MyHPVscore™ - a reliable blood test that helps detect HPV-driven head and neck cancers.
Using advanced technology, MyHPVscore™ measures fragments of circulating HPV DNA, a marker shed by cancer cells into the blood. This test is highly accurate, making it a dependable tool for uncovering HPV-positive head and neck cancers at various stages of care.
With MyHPVscore™, you can gain valuable insights into your health and take proactive steps towards managing HPV-related cancers effectively.
Overall, HPV ctDNA tests from plasma offer a non-invasive and sensitive approach for detecting HPV ctDNA in individuals at risk of HPV-related cancers, potentially enabling earlier diagnosis of disease recurrence and personalized management of the disease. However, it's essential to interpret the results of this lab developed test within the context of the patient's clinical history and other diagnostic findings for accurate assessment and appropriate management.
Email a representative about ordering the MyHPVscore test.
Resources
- Learn more about the researchers who developed the MyHPVscore test:
- Learn more about Head & Neck Cancer Care
- Learn more about HPV circulating tumor DNA medical research at the University of Michigan
- Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma
- Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma
- Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma